Study of a diabetes drug combination in healthy adults
Part of Hormones & metabolism clinical trials.
This study tests an investigational combination tablet for diabetes. It looks at how food affects the drug and how the body handles it when taken multiple times.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 45 years old.
- Your body mass index (BMI) must be between 19.0 and 26.0.
- You must not have any serious medical conditions or allergies.
- You must be willing to avoid pregnancy (or sperm donation) for 3 months after the study.
- You must be able to follow dietary restrictions, such as avoiding grapefruit and alcohol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new pill, chiglitazar, can help lower blood sugar when added to your current diabetes medicine (an SGLT-2 inhibitor). It may be an option if your blood sugar is still not well controlled.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This trial tests a new combination pill that includes three medications to lower blood sugar in people with type 2 diabetes. It aims to see if this combination is safe and effective for Chinese patients.
This trial tests a new oral medication, Chiglitazar, for people who have both type 2 diabetes and a fatty liver condition called MASH (fatty liver with inflammation and scarring). It aims to see if the drug can help improve liver health and diabetes control.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This study tests how three common diabetes medicines (dapagliflozin, linagliptin, and metformin) are absorbed when taken with food in healthy adults. It helps doctors understand safe dosing and potential interactions.
Hear when a new T2DM (Type 2 Diabetes Mellitus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.